Table 2 Drugs classified as fall-risk increasing drugs in the IMPROveFALL study
Category | Drug type |
|---|---|
Central nervous system | anxiolytics/hypnotics (benzodiazepines and others); antidepressants (tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and monoamine oxidase inhibitors), neuroleptics (dopamine D2-receptor agonists and serotonin dopamine receptor antagonists) |
Cardiovascular | Antihypertensives (diuretics, beta-adrenoceptor blockers, alpha-adrenoceptor blockers, centrally acting antihypertensives, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers); Anti-arrhythmic drugs (Antiarrhythmics, nitrates, digoxin, vasodilators) |
Anti-inflammation | NSAIDs |
Gastro-Intestinal | Antacids (H-2 receptor antagonists) |
Analgesics | Opioids |
Pulmonary | Sympathomimetics, anti-histaminics |
Diuretics | Thiazide diuretics, loop diuretics |